| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/08/2001 | WO2001008693A2 Combination therapy using pentafluorobenzenesulfonamide and platin compound |
| 02/08/2001 | WO2001008691A1 Methods for transdifferentiation of body tissues |
| 02/08/2001 | WO2001008689A1 Ophthalmic compositions containing antibiotics and nsaids |
| 02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | WO2001008684A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 02/08/2001 | WO2001008683A1 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 02/08/2001 | WO2001008682A2 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 02/08/2001 | WO2001008680A1 Preparations for reducing oxygen consumption during physical efforts |
| 02/08/2001 | WO2001008679A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/08/2001 | WO2001008677A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | WO2001008676A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | WO2001008675A1 Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients |
| 02/08/2001 | WO2001008673A1 Calcilytic compounds |
| 02/08/2001 | WO2001008672A2 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | WO2001008671A2 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | WO2001008670A2 Methods and compositions for alleviating stuttering |
| 02/08/2001 | WO2001008657A2 Personal care articles |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000070017A3 Methods using of fab i and compounds modulating fab i activity |
| 02/08/2001 | WO2000069449A3 Conditioned cell culture medium compositions and methods of use |
| 02/08/2001 | WO2000067798A3 Enhanced delivery of nucleic acid-based drugs |
| 02/08/2001 | WO2000066141A3 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000063406A3 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000059525A3 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 02/08/2001 | WO2000057729A3 Beverages for treatment of glucose metabolism disorders |
| 02/08/2001 | WO2000056737A3 Calanolides for inhibiting btk |
| 02/08/2001 | WO2000048617A3 Connective tissue softening |
| 02/08/2001 | WO2000048446A3 Use of antagonists of pg-e for the treatment of neuropathic pain |
| 02/08/2001 | WO2000024365A8 Treatment of skin with adenosine or adenosine analog |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2388297A1 Ophthalmic compositions containing antibiotics and nsaids |
| 02/08/2001 | CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2380473A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | CA2380428A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2380111A1 Controlled release implantable devices |
| 02/08/2001 | CA2380081A1 Calcilytic compounds |
| 02/08/2001 | CA2380009A1 Methods of inhibiting osteoclastogenesis |
| 02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | CA2379953A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | CA2379703A1 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | CA2379538A1 Personal care articles |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378302A1 Thienopyranecarboxamide derivatives |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/08/2001 | CA2378140A1 Methods for transdifferentiation of body tissues |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/08/2001 | CA2362785A1 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | CA2345753A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
| 02/07/2001 | EP1074634A1 Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease |
| 02/07/2001 | EP1074618A2 Cadherin materials and methods |
| 02/07/2001 | EP1074268A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists |
| 02/07/2001 | EP1074259A1 Preventives for alcoholic gastritis |
| 02/07/2001 | EP1074258A2 Methods and compositions for treating diseases and conditions of the eye |
| 02/07/2001 | EP1074251A1 Adhesive preparations |
| 02/07/2001 | EP1074244A2 Topical composition comprising a tocopherol compound |
| 02/07/2001 | EP1073771A1 New method for the selection of clones of an eypression library involving rearraying |
| 02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
| 02/07/2001 | EP1073729A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073728A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073666A1 Composition for treatment of external secretion disorders except hypolacrimation |
| 02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |
| 02/07/2001 | EP1073455A1 Compositions and methods for extending the action of clostridial neurotoxin |
| 02/07/2001 | EP1073436A1 IMPROVED METHOD FOR ERADICATION OF $i(HELICOBACTER PYLORI) |
| 02/07/2001 | EP1073432A2 Use of glycine site agonists or glycine uptake inhibitors for treating neuropsychiatric disorders |
| 02/07/2001 | EP1073431A1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 02/07/2001 | EP1073430A1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 02/07/2001 | EP1073418A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 02/07/2001 | EP1073416A1 Use of inhaled no as anti-inflammatory agent |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | EP1033997A4 Method of mobilizing hematopoietic stem cells |
| 02/07/2001 | EP0904084A4 Emergency contraceptive kit |
| 02/07/2001 | CN1283234A Method for suppressing multiple drug resistant in cancer cells |
| 02/07/2001 | CN1283116A Method of reducing craving in mamals |
| 02/06/2001 | US6184357 Antibody which binds a preferential polypeptide; for the diagnosis, prevention and treatment of prostate cancer and hyperplasia |
| 02/06/2001 | US6184351 Artificial brain protein; for the treatment of alzheimer's and parkinson's disease |
| 02/06/2001 | US6184256 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/06/2001 | US6184250 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 02/06/2001 | US6184248 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 02/06/2001 | US6184222 Administering norepinephrine reuptake inhibitor selective for norepinephrine over other neurotransmitters; side effect reduction |
| 02/06/2001 | US6184219 Composition and methods employing it for the treatment of 5-HT-mediated disorders |
| 02/06/2001 | US6184218 Mixture of citalopram and (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5 -carboxamide hydrogen (2r,3r)-tartrate monohydrate (nad-299); antidepressants |
| 02/06/2001 | US6184215 Treatment of skin conditions with oxysterol activators of LXRα |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183776 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |